Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of LLF580 in Obese Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line
- Status
- COMPLETED
- Phase
- PHASE3
Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients
- Status
- WITHDRAWN
- Phase
- PHASE2
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
- Status
- TERMINATED
- Phase
- PHASE3
Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome
- Status
- COMPLETED
- Phase
- PHASE4
Study of Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of LNP023 in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant
- Status
- COMPLETED
- Phase
- PHASE3
Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)
- Status
- COMPLETED
- Phase
- PHASE2
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Calcineurin Inhibitors (CNIs) to Everolimus
- Status
- COMPLETED
- Phase
- N/A
Unifying Advanced Treatment With Advanced Imaging
- Status
- COMPLETED
- Phase
- N/A
VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib
- Status
- TERMINATED
- Phase
- PHASE1